Biosimilars – A different strategy for the diabetes battle

PM Healthcare events are Quality Assured by the University of Bradford

Satellite	Biosimilars – A different strategy for the diabetes battle
Speakers	Sally James (Divisional Pharmacist for Unscheduled Care, Royal Liverpool and Broadgreen University Hospital, NHS Trust)
Satellite Description
By the end of this session you will: Understand the different strategies tried to achieve good outcomes in type 2 diabetes Understand what biosimilar insulin is Outline the evidence that supports the safety of biosimilars Consider how the availability of biosimilar insulin will impact clinical practice Consider how biosimilars can contribute to sustainable medicine systems This session is organised and funded by Mylan
Sponsored By	Mylan